Xemocid Gold
IV Infusion
Beacon Pharmaceuticals Ltd.Generic:
Amino Acid + Glucose + ElectrolytesWeight:
7%+10%best Price:
৳551.64Generic
Amino Acid + Glucose + Electrolytes
Pharmacology
Each 100 ml contains- Essential Amino Acids: L-Isoleucine 0.390 gm L-Leucine 0.530 gm L-Lysine Hydrochloride 0.390 gm L-Methionine 0.190 gm L-Phenylalanine 0.550 gm L-Threonine 0.300 gm L-Tryptophan 0.100 gm L-Valine 0.430 gm L-Histidine 0.240 gm L-Tyrosine 0.050 gm Non-Essential Amino Acids: L-Arginine 0.330 gm L-Aspartic Acid 0.410 gm L-Glutamic Acid 0.900 gm L-Alanine 0.300 gm L-Cystine 0.140 gm Glycine (Aminoacetic Acid) 0.210 gm L-Proline 0.810 gm L-Serine 0.750 gm Carbohydrate: Anhydrous Glucose 10.00 gm Electrolytes: Sodium (Na+) 50.0 mmol/L Potassium (K+) 20.0 mmol/L Calcium (Ca++) 2.5 mmol/L Magnesium (Mg++) 1.5 mmol/L Chloride (Cl-) 32.0 mmol/L
Contraindications
This preparation is usually well tolerated. Nausea occurs rarely. Vomiting, flushing and sweating have been observed during infusion of the solution at rates exceeding the recommended maximal rate. Transient increases in liver test during intravenous nutrition have been reported. The reasons are at present unclear. The underlying disease and the components and their amount in the intravenous feeding regimens have been suggested. Hypersensitivity reactions have been reported. As with all hypertonic infusion solution, thrombophlebitis may occur when peripheral veins are used. The incidence may be reduced by the simultaneous infusion of 10% fat emulsion.
Side Effects
Successful and safe administration of amino acid solution during pregnancy in human has been reported. Animal reproduction studies have not been carried out with 7% amino acid IV infusion with 10% glucose & electrolytes.
Pregnancy And Lactation
Hyperphenylalaninemia has been noted in severely ill, premature infants. In these patients, monitoring of the phenylalanine level is recommended and the infusion rate to be adjusted as needed. This preparation should be used with caution in patients with diabetes mellitus, severe heart failure or with renal function in combination with fluid restriction or oliguria/anuria of other origin. In patient with hyperglycemia, administration of exogenous insulin might be necessary. Do not use if the solution is turbid or contains particles. Discard any unused portion.
Therapeutic
Successful and safe administration of amino acid solution during pregnancy in human has been reported. Animal reproduction studies have not been carried out with 7% amino acid IV infusion with 10% glucose & electrolytes.
Storage Conditions
Hyperphenylalaninemia has been noted in severely ill, premature infants. In these patients, monitoring of the phenylalanine level is recommended and the infusion rate to be adjusted as needed. This preparation should be used with caution in patients with diabetes mellitus, severe heart failure or with renal function in combination with fluid restriction or oliguria/anuria of other origin. In patient with hyperglycemia, administration of exogenous insulin might be necessary. Do not use if the solution is turbid or contains particles. Discard any unused portion.